intal forte
sanofi-aventis new zealand limited - sodium cromoglicate 5mg equivalent to 3.5211% w/w; ; - aerosol inhaler, metered dose - 5 mg/dose - active: sodium cromoglicate 5mg equivalent to 3.5211% w/w excipient: apaflurane macrogol 600 povidone - intal forte 5 mg cfc-free is indicated for the preventive treatment of bronchial asthma (which may be due to allergy, exercise, cold air or chemical irritants) in adults and children.
symbicort rapihaler 100/6
astrazeneca limited - budesonide 80ug; ; ; ; formoterol fumarate 4.5ug; - aerosol inhaler, metered dose - 100/6 - active: budesonide 80ug formoterol fumarate 4.5ug excipient: apaflurane macrogol 1000 povidone - symbicort rapihaler 100/6 is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting beta2-agonist) is appropriate. this includes: · patients who are not adequately controlled with inhaled corticosteroid therapy and ?as needed? inhaled short-acting beta-2 adrenoceptor agonists. · patients who are already adequately controlled on regular separate long acting beta-agonist and inhaled corticosteroid therapies.
symbicort rapihaler 200/6
astrazeneca limited - budesonide 160ug; ; ; ; formoterol fumarate 4.5ug; - aerosol inhaler, metered dose - 200/6 - active: budesonide 160ug formoterol fumarate 4.5ug excipient: apaflurane macrogol 1000 povidone - symbicort rapihaler 100/6 is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting beta2-agonist) is appropriate. this includes: · patients who are not adequately controlled with inhaled corticosteroid therapy and ?as needed? inhaled short-acting beta-2 adrenoceptor agonists. · patients who are already adequately controlled on regular separate long acting beta-agonist and inhaled corticosteroid therapies.
yervoy
bristol-myers squibb (nz) limited - ipilimumab 5 mg/ml; - concentrate for injection - 200 mg/40 ml - active: ipilimumab 5 mg/ml excipient: hydrochloric acid mannitol nitrogen pentetic acid polysorbate 80 sodium chloride sodium hydroxide trometamol hydrochloride water for injection - yervoy, as monotherapy, is indicated for the treatment of patients with unresectable or metastatic melanoma in adults, 18 years of age or older. yervoy, in combination with opdivo (ipilimumab), is indicated for the treatment of patients with unresectable or metastatic disease melanoma.
yervoy
bristol-myers squibb (nz) limited - ipilimumab 5 mg/ml; - concentrate for injection - 50 mg/10 ml - active: ipilimumab 5 mg/ml excipient: hydrochloric acid mannitol nitrogen pentetic acid polysorbate 80 sodium chloride sodium hydroxide trometamol hydrochloride water for injection - yervoy, as monotherapy, is indicated for the treatment of patients with unresectable or metastatic melanoma in adults, 18 years of age or older. yervoy, in combination with opdivo (ipilimumab), is indicated for the treatment of patients with unresectable or metastatic disease melanoma.
flagyl suspension
sanofi israel ltd - metronidazole as benzoate - suspension - metronidazole as benzoate 25 mg/ml - metronidazole - metronidazole - infections caused by anaerobic bacterias, amebiosis, lambliasis and trichomonas.
flagyl 250 mg tablets
sanofi israel ltd - metronidazole - film coated tablets - metronidazole 250 mg - metronidazole - metronidazole - trichomonias, acute intestinal amebiasis. infections due to anaerobic bacteria, lambliasis.
navelbine 20 mg
padagis israel agencies ltd, israel - vinorelbine as tartrate - capsules - vinorelbine as tartrate 20 mg - vinorelbine - vinorelbine - for the treatment of non small cell lung cancer. for the treatment of advanced breast cancer.
navelbine 30 mg
padagis israel agencies ltd, israel - vinorelbine as tartrate - capsules - vinorelbine as tartrate 30 mg - vinorelbine - vinorelbine - for the treatment of non small cell lung cancer. for the treatment of advanced breast cancer.
celcox 200 mg
trima israel pharmaceutical products maabarot ltd - celecoxib - capsules - celecoxib 200 mg - celecoxib - celecoxib - symptomatic treatment of inflammation and pain in osteoarthritis (oa) and rheumatoid arthritis (ra).